The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN
DMM Disease Models and Mechanisms - United Kingdom
doi 10.1242/dmm.024448
Full Text
Open PDFAbstract
Available in full text
Date
July 7, 2016
Authors
Publisher
The Company of Biologists